Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Hoogenboezem RM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-2 z 2
    Tytuł:
    Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2 -Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient.
    Autorzy:
    Meijer TG; Department of Molecular Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Department of Pathology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Oncode Institute, 3521 AL Utrecht, The Netherlands.
    Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Prager-van der Smissen WJC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Verkaik NS; Department of Molecular Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Oncode Institute, 3521 AL Utrecht, The Netherlands.
    Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    van Herk S; Oncode Institute, 3521 AL Utrecht, The Netherlands.; Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Robert-Finestra T; Oncode Institute, 3521 AL Utrecht, The Netherlands.; Department of Developmental Biology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Hoogenboezem RM; Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Ruigrok-Ritstier K; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Paul MW; Department of Molecular Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Oncode Institute, 3521 AL Utrecht, The Netherlands.
    Gribnau J; Oncode Institute, 3521 AL Utrecht, The Netherlands.; Department of Developmental Biology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Bindels EMJ; Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Kanaar R; Department of Molecular Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Oncode Institute, 3521 AL Utrecht, The Netherlands.
    Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    van Gent DC; Department of Molecular Genetics, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.; Oncode Institute, 3521 AL Utrecht, The Netherlands.
    Hollestelle A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2024 Feb 10; Vol. 16 (4). Date of Electronic Publication: 2024 Feb 10.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation.
    Autorzy:
    Zhao M; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Kiernan CH; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Stairiker CJ; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Hope JL; Cancer Immunology and Tumor Microenvironment Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States of America.
    Leon LG; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    van Meurs M; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Brouwers-Haspels I; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Boers R; Department of Developmental Biology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Oncode Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Boers J; Department of Developmental Biology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Oncode Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Gribnau J; Department of Developmental Biology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Oncode Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
    van IJcken WFJ; Center for Biomics, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Bindels EM; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Hoogenboezem RM; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Erkeland SJ; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Mueller YM; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Katsikis PD; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Pokaż więcej
    Źródło:
    PLoS pathogens [PLoS Pathog] 2020 Jun 24; Vol. 16 (6), pp. e1008555. Date of Electronic Publication: 2020 Jun 24 (Print Publication: 2020).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    CD8-Positive T-Lymphocytes/*immunology
    DNA Methylation/*immunology
    Hepatocyte Nuclear Factor 1-alpha/*immunology
    Lymphocytic Choriomeningitis/*immunology
    Lymphocytic choriomeningitis virus/*immunology
    Promoter Regions, Genetic/*immunology
    Animals ; CD8-Positive T-Lymphocytes/pathology ; Hepatocyte Nuclear Factor 1-alpha/genetics ; Lymphocytic Choriomeningitis/genetics ; Lymphocytic Choriomeningitis/pathology ; Lymphocytic choriomeningitis virus/genetics ; Mice ; Mice, Transgenic ; Signal Transduction/genetics ; Signal Transduction/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-2 z 2

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies